Market View 26th March 2024

View on market: Volatility Prevails, Market is searching for better value

Tuesday’s early trading saw most Asian-Pacific markets decline as they followed Wall Street’s overnight losses. The S&P ASX 200 was down 4.50 points, or 0.058, at 7,807.40, while the Nikkei 225 was up 21.53 points, or 0.053%, at 40,435.65. According to Bloomberg, the U.S. stock market’s rally has paused, but it is still expected to reach its peak week in 2024 due to expectations that the Federal Reserve may be able to lower interest rates as early as June. As of Monday, the Nasdaq Composite and S&P 500 index had both dropped by 0.27% and 0.31%, respectively. At the close, the Dow Jones Industrial Average was down 0.41%. A barrel of Brent crude was trading 0.09% higher at $86.84. An ounce of gold was trading at $2,174.05, up 0.10%.

Economic Calendar:

• USD : CB Consumer Confidence (Mar) on 26^th March, 2024
• USD : GDP (QoQ) (Q4) on 28^th March, 2024
• INR : Current Account (USD) on 28^th March, 2024
• INR : Foreign Debt (USD) on 28^th March, 2024

Brokerage Radar:

INVESTEC ON BSE: Upgrade to Buy, TP Rs 2800; Believe contribution to SGF during Q3’24, is a one-off cost & unlikely to recur; Furthermore, BSE has managed to reduce clearing charges paid to NSE by 30% QoQ on per Rs 1mn basis; Expect improved margin profile in Q4’24e

MS ON MARUTI: UW, TP Rs 475; Wipro has appointed Anne-Marie (Annie) Rowland as Capco’s Chief Executive Officer effective April 1, 2024. Rowland has been with Capco for 14 years & has held multiple executive roles on Capco global leadership team

Expect transition to be a smooth one

International Markets:

U.S & Europe:

Asian markets:

ADR Watch:

Commodities & Currency:

FIIs & DIIs:

News Update:

UltraTech Cement: The company commissioned 1 MTPA brownfield cement capacity at the Uttarakhand unit. The total unit capacity is now at 2.1 MTPA.

ICICI Securities: The company received a warning from SEBI after an inspection of its books and records for merchant banking activities.

JSW Energy: The company’s step-down unit is in a pact with Reliance Power to acquire a 45 MW wind power project in Maharashtra for Rs 132 crore.

Lupin: The company will sell its trade generics businesses in India to arm for Rs 100–120 crore on a slump sale basis.

Hindustan Aeronautics: The company has received an order worth Rs 194 crore from the Guyana Defence Force.

Sanghi Industries: Promoter Ambuja Cements sold a 2% stake in the company for Rs 258 crore. The promoter’s stake currently stands at 60.44%.

Eicher Motors: The company incorporated its wholly owned subsidiary in the Netherlands, named Royal Enfield Europe BV.

Dr Reddy’s Laboratories: The company has entered into a licence agreement with Pharmazz to commercialise the first-in-class innovative drug Centhaquine in India.

UNO Minda: The company has entered into a technical licence agreement with Starcharge Energy to manufacture and sell electric vehicle supply equipment in India.

Schaeffler India: The company has reappointed Harsha Kadam as the managing director and chief executive officer for three years, effective from Oct. 1.

Raymond: The board approved selling the entire investment in wholly owned subsidiaries Raymond Apparel and Ultrashore Realty for a consideration of Rs 1.26 crore.

Garden Reach Shipbuilders & Engineers: The company has signed a contract worth Rs 26.45 crore with the Ministry of External Affairs for a fast patrol vessel.

Exide Industries: The company made an investment of Rs 110 crore in arm Chloride Metals via rights basis.

Medplus Health Services: The company has received a temporary suspension order for two of its stores.

Maruti Suzuki India: The company recalls 11,185 units of the Baleno and 4,190 units of the Wagon R on a possible fuel pump motor defect. It also agreed to acquire a 6.44% stake in Amlgo Labs for Rs 1.99 crore.

Reliance Industries: The company acquired a 100% stake in MSKVY Nineteenth Solar SPV and MSKVY Twenty-second Solar SPV from MSEB Solar Agro Power.

Source: Moneycontrol, Bloomberg Quint, Investing 

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and

(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.

For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale.

Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

1. Reports
2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;

(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

2. Compensation

(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;

(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;

(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(d) EWL  or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.

3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL

Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.